Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Tampilan
• 07/09/23
0
0
Menanamkan
administrator
Pelanggan
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru